William Vermi

29PUBLICATIONS
167CO-AUTHORS
Molecular targetsPredictive and prognostic markersOncology and carcinogenesis not elsewhere classifiedCancer therapy (excl. chemotherapy and radiation therapy)Cancer diagnosis
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (29)

|Sep 01, 2026
Comprehensive genomic profiling of mucosal melanoma reveals novel fusion transcripts and dysregulation of cell-cycle, MAPK, and PI3K pathways.

|Aug 27, 2026
Catalase Defines Radiotherapy Resistance and a Therapeutic Vulnerability in Rhabdomyosarcoma.

|Mar 06, 2026
Integrating interferon gamma receptor pathways, antigenicity, and immune contexture as predictors of immunotherapeutic strategies for mucosal melanomas.

Matilde Monti, Sara Picinoli, Anna Bozzola

|Feb 13, 2026
Outcomes for Sinonasal Undifferentiated Carcinoma (SNUC): An International Multi-Center Retrospective Cohort Study.

Jacklyn Liu, Yoko Takahashi, Umar Rehman

|Dec 17, 2025
CD300e is a driver of the immunosuppressive tumor microenvironment and colorectal cancer progression via macrophage reprogramming.

Annica Barizza, Stefania Vassallo, Laura Masatti

|Jul 10, 2025
Biomarker testing implementation for molecularly targeted therapy in non-small cell lung cancer patients.

Daniele Lorenzini, Gabriella Gaudioso, Alessandro Scardoni

Pageof 5

Frequent Collaborators

7 joint publications

Emanuele Giurisato

5 joint publications

Silvia Lonardi

5 joint publications

Francesco Missale

3 joint publications

Marco A Cassatella